Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 168


Hepatic CD147 knockout modulates liver steatosis and up-regulates autophagy in high-fat-diet-induced NAFLD mice.

Lou J, Li C, Li ZS, Zhang T, Chen ZN, Bian H.

Biochem Biophys Res Commun. 2020 Feb 13. pii: S0006-291X(20)30249-7. doi: 10.1016/j.bbrc.2020.01.164. [Epub ahead of print]


CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ.

Chen R, Wang K, Feng Z, Zhang MY, Wu J, Geng JJ, Chen ZN.

Cell Mol Immunol. 2020 Jan 3. doi: 10.1038/s41423-019-0353-7. [Epub ahead of print]


Identification of differentially expressed genes in non-small cell lung cancer.

Wang K, Chen R, Feng Z, Zhu YM, Sun XX, Huang W, Chen ZN.

Aging (Albany NY). 2019 Dec 9;11(23):11170-11185. doi: 10.18632/aging.102521. Epub 2019 Dec 9.


Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy.

Zhang RY, Wei D, Liu ZK, Yong YL, Wei W, Zhang ZY, Lv JJ, Zhang Z, Chen ZN, Bian H.

Front Cell Dev Biol. 2019 Oct 11;7:233. doi: 10.3389/fcell.2019.00233. eCollection 2019.


Synthesis and Evaluation of a Novel Small-molecule Compound as an Anticancer Inhibitor of CD147.

Fu ZG, Wang Y, Wang S, Shao D, Tian L, Li YX, Jiang JL, Chen ZN, Wen N.

Biomed Environ Sci. 2019 Sep;32(9):673-686. doi: 10.3967/bes2019.086.


Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer.

Li YM, Yu JM, Liu ZY, Yang HJ, Tang J, Chen ZN.

Int J Mol Sci. 2019 Oct 17;20(20). pii: E5138. doi: 10.3390/ijms20205138.


TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis.

Zheng M, Zhang X, Zhou Y, Tang J, Han Q, Zhang Y, Ni Q, Chen G, Jia Q, Yu H, Liu S, Robins E, Jiang NJ, Wan Y, Li QJ, Chen ZN, Zhu P.

EBioMedicine. 2019 Sep;47:414-426. doi: 10.1016/j.ebiom.2019.07.032. Epub 2019 Aug 30.


Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.

Liu ZK, Zhang RY, Yong YL, Zhang ZY, Li C, Chen ZN, Bian H.

PeerJ. 2019 Aug 8;7:e7436. doi: 10.7717/peerj.7436. eCollection 2019.


Publisher Correction: Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling.

Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X.

Nature. 2019 Aug;572(7770):E20. doi: 10.1038/s41586-019-1480-0.


Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling.

Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X.

Nature. 2019 Aug;572(7769):402-406. doi: 10.1038/s41586-019-1426-6. Epub 2019 Jul 24. Erratum in: Nature. 2019 Aug 2;:.


Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells.

Fan XY, He D, Sheng CB, Wang B, Wang LJ, Wu XQ, Xu L, Jiang JL, Li L, Chen ZN.

Am J Transl Res. 2019 Jun 15;11(6):3543-3554. eCollection 2019.


RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.

Liu ZY, Zheng M, Li YM, Fan XY, Wang JC, Li ZC, Yang HJ, Yu JM, Cui J, Jiang JL, Tang J, Chen ZN.

Theranostics. 2019 Jun 2;9(12):3659-3673. doi: 10.7150/thno.32126. eCollection 2019.


Gamma-secretase complex-dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma.

Yong YL, Zhang RY, Liu ZK, Wei D, Shang YK, Wu J, Zhang ZY, Li C, Chen ZN, Bian H.

J Pathol. 2019 Oct;249(2):255-267. doi: 10.1002/path.5316. Epub 2019 Aug 6.


CNOT3 contributes to cisplatin resistance in lung cancer through inhibiting RIPK3 expression.

Jing L, Zhai ME, Cui J, Fan XY, Cheng YY, Jiang JL, Chen ZN.

Apoptosis. 2019 Aug;24(7-8):673-685. doi: 10.1007/s10495-019-01550-y.


3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab.

Li Y, Zhang T, Pang Y, Li L, Chen ZN, Sun W.

Biofabrication. 2019 Jun 26;11(3):034102. doi: 10.1088/1758-5090/ab256c.


Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.

Li YM, Liu ZY, Wang JC, Yu JM, Li ZC, Yang HJ, Tang J, Chen ZN.

Hepatology. 2019 Nov;70(5):1564-1581. doi: 10.1002/hep.30676. Epub 2019 Jul 17.


Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.

Jin J, Wang SJ, Cui J, Li L, Li JY, Liu FL, Sun XX, Jiang JL, Cui HY, Chen ZN.

Cell Oncol (Dordr). 2019 Aug;42(4):537-554. doi: 10.1007/s13402-019-00444-0. Epub 2019 Apr 23.


A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer.

Huhe M, Lou J, Zhu Y, Zhao Y, Shi Y, Wang B, Sun X, Zhang X, Zhang Y, Chen ZN.

Biochem Biophys Res Commun. 2019 Jun 11;513(4):1083-1091. doi: 10.1016/j.bbrc.2019.04.046. Epub 2019 Apr 19.


MFGE8 protects against CCl4 -induced liver injury by reducing apoptosis and promoting proliferation of hepatocytes.

Li H, Zhang T, Wang K, Lu M, Guo Y, Zhang Y, Chen ZN, Bian H.

J Cell Physiol. 2019 Feb 14. doi: 10.1002/jcp.28314. [Epub ahead of print]


Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.

Li YM, Liu ZY, Li ZC, Wang JC, Yu JM, Yang HJ, Chen ZN, Tang J.

Int J Mol Sci. 2019 Jan 3;20(1). pii: E156. doi: 10.3390/ijms20010156.

Supplemental Content

Loading ...
Support Center